A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose Technology. Journal Abstract

A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose Technology.

Publication Date: 2024 Sep

Full Text Sources

Authors

Gaetano Rocco; Giorgio Pennazza; Kay See Tan; Stijn Vanstraelen; Marco Santonico; Robert J Corba; Bernard J Park; Smita Sihag; Matthew J Bott; Pierfilippo Crucitti; James M Isbell; Michelle S Ginsberg; Hallie Weiss; Raffaele Antonelli Incalzi; Panaiotis Finamore; Filippo Longo; Alessandro Zompanti; Simone Grasso; Stephen B Solomon; Alain Vincent; Alexa McKnight; Michael Cirelli; Carmela Voli; Susan Kelly; Mario Merone; Daniela Molena; Katherine Gray; James Huang; Valerie W Rusch; Manjit S Bains; Robert J Downey; Prasad S Adusumilli; David R Jones

Abstract

OBJECTIVE

Electronic nose (E-nose) technology has reported excellent sensitivity and specificity in the setting of lung cancer screening. However, the performance of E-nose specifically for early-stage tumors remains unclear. Therefore, the aim of our study was to assess the diagnostic performance of E-nose technology in clinical stage I lung cancer.

Source

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Pub Types(s)

Journal Article

Language

English

PubMed ID

38762120